The FDA was expected to decide on the application of sotorasib and panitumumab for the treatment of metastatic colorectal ...
The regulator has delayed its respective decision dates on whether to grant full approval to Amgen’s Lumakras in metastatic ...
The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...